Wendy Blosser
Amministratore Delegato presso ACCUSTEM SCIENCES, INC.
Patrimonio netto: 940 $ in data 31/05/2024
Profilo
Wendy Blosser is currently the Chief Executive Officer & Director at AccuStem Sciences, Inc. She previously held positions as Vice President-Sales at Integrated Oncology Solutions, Inc., Chief Commercial Officer at Biodesix, Inc., and Chief Commercial Officer at Agendia, Inc. From 2019 to 2021, she served as the Chief Commercial Officer at Agendia NV.
Ms. Blosser completed her undergraduate degree at Marietta College and her graduate degree at West Virginia University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ACCUSTEM SCIENCES INC
0.02% | 31/12/2023 | 2 000 ( 0.02% ) | 940 $ | 31/05/2024 |
Posizioni attive di Wendy Blosser
| Società | Posizione | Inizio |
|---|---|---|
| ACCUSTEM SCIENCES, INC. | Amministratore Delegato | 04/03/2022 |
Precedenti posizioni note di Wendy Blosser
| Società | Posizione | Fine |
|---|---|---|
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Corporate Officer/Principal | 01/03/2021 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | - |
| Integrated Oncology Solutions, Inc. | Vendite & Marketing | - |
| BIODESIX, INC. | Corporate Officer/Principal | - |
Formazione di Wendy Blosser
| Marietta College | Undergraduate Degree |
| West Virginia University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIODESIX, INC. | Health Services |
| ACCUSTEM SCIENCES, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Integrated Oncology Solutions, Inc. | |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
- Borsa valori
- Insiders
- Wendy Blosser
